Sarah Ford | April 18, 2014
Researcher Examines Impact of Extra Chromosome on Acute Myeloid Leukemia
David Gordon, MD, PhD at Dana Farber Cancer Institute is a CureSearch Young Investigator examining the impact of trisomy 8 on acute myeloid leukemia (AML). Of the 500 children diagnosed with AML each year, between 10-20% of an extra chromosome 8, called trisomy 8.
Dr. Gordon suspects that trisomy 8 contributes to the creation of cancerous cells because certain genes are expressed when an abnormal number of chromosomes are present. Using three cell lines he previously developed, Dr. Gordon spent the first year of his CureSearch grant screening the cell lines for new AML target genes and investigating the impact of trisomy 8 in blood cell development.
In the coming year, Dr. Gordon will explore how these genes, and their interaction with trisomy 8, lead to the development of AML.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Women’s Health Month
May is Women’s Health Month, a time when we focus on the importance of taking care of ourselves and our health. This month is an…
Read Article
Military Spouse Appreciation Day
May 10 marks the celebration of Military Spouse Appreciation Day, a time to honor and recognize the immense contributions made by military spouses in supporting…
Read Article
Melanoma and Skin Cancer Awareness Month
Melanoma is an aggressive form of skin cancer. In addition to the skin, melanoma may also occur in mucous membranes – thin, moist layers of tissue that cover surfaces…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
